Press release
Will Demand for Personalized Medicines Boost Sales in the Global Single-use Bioprocessing Market? | Arizton
The introduction of advanced integrated equipment will transform the global single-use bioprocessing market.Arizton’s recent market research report on the global single-use bioprocessing market provides comprehensive industry analysis, trend forecasts, and competitive analysis. The research study segments the market by product (simple & peripheral devices and single-use bioprocessing equipment), by application (filtration, storage & transfer, cell culture, mixing, and purification), by end-users (biopharmaceuticals manufacturing companies, CMOs, and R&D companies & research institutes), by geography (North America, Europe, APAC, Latin America, and MEA), and offers detailed competitive analysis.
The global single-use bioprocessing market is expected to generate revenues of around $7 billion by 2024, growing at a CAGR of over 14% during 2018-2024.
The exponential advancement in the life science industry and the increasing number of patients opting for biosimilars and biopharmaceuticals is driving the growth of the global single-use bioprocessing market. The phenomenal performance of SUTs in various bioprocessing applications and the wider adoption at commercial scale manufacturing will augment the development of the global market over the next few years.
Request for your free sample today!
https://www.arizton.com/market-reports/single-use-bioprocessing-market
The top 3 drivers and trends positively impacting the market are discussed below:
Growing Demand for Flexible and Custom Biopharmaceutical Manufacturing Facilities
The rising demand for flexible and custom biopharmaceutical manufacturing facilities is propelling the growth of the global single-use bioprocessing market. The biopharmaceutical industry is experiencing dynamic changes with biopharmaceuticals go off-patent, the emergence of new treatments, and drug pipelines are becoming increasingly diverse in the market. The increasing focus of the healthcare industry to initiate reforms and provide quality patient care at affordable prices will boost revenues in the global single-use bioprocessing market. The increasing prevalence of rare and chronic diseases, growing focus on personalized medicine, localized manufacturing, and the ability to adapt quickly as per changing dynamics will drive the need for flexible manufacturing. The growing number of flexible manufacturing facilities will create lucrative opportunities for leading vendors in the market. The growing incorporation of SUTs and the implementation of SUB offers end-users flexibility in terms of scalability, production mode, mixing, and volumes in the market. The introduction of advanced integrated equipment will transform the global single-use bioprocessing market.
New Product Launches
The increasing focus on the development and launch new products will propel the development of the global single-use bioprocessing market. New product approvals/launches coupled with R&D activities help the vendors to expand their presence, enhance market growth, and sustain their position in the global market. The leading vendors are actively engaged in R&D activities and plan to launch innovative products. Companies such as Sartorius Stedim Biotech, Danaher (Pall), Merck KGaA, and Thermo Fisher Scientific are contributing a great deal in the global single-use bioprocessing market, and will launch innovative products. The vendors are investing in the new products approvals from regulatory bodies, which in turn, will positively impact the global market during the forecast period. Some of the recent product launches in the market are New Mini Microcarrier Bioreactor for ambr high throughput system, Allegro STR 50 L bioreactor, ambr 250 high throughput (ht) bioreactor system for perfusion culture, Helium Integrity Test (HIT) system, Allegro Fully Automated, Single-Use Chromatography System, and StaxmAx clarification platform, etc. With the initiatives to get maximum product approvals vendors will try and gain larger global single-use bioprocessing market share of the next few years.
Request for your free sample today!
https://www.arizton.com/market-reports/single-use-bioprocessing-market
Technological Advancements/Improvements in Single-use Bioprocessing
The growing focus on technological advances and improvements is propelling the growth of the global single-use bioprocessing market. The development of several advanced and innovative single-use technology will help vendors gain a larger market share during the forecast period. The innovations in term of product design, production enhancement, and efficiency will fuel the growth of the market.The growing demand for biopharmaceuticals and biosimilars has encouraged many pharma and biotech companies to purchase several single-use systems and disposables. SUT has a wide range of application and use for different biomanufacturing processes such as filtration, upstream expression, mixing, purification, formulation, separations, and filling. The increasing availability of many products such as disposable filter cartridges, tangential flow filters, depth filters, tubing, and connectors suitable for downstream processing applications will transform the global single-use bioprocessing market.
The leading vendors in the market are Thermo Fisher Scientific, Sartorius Stedim Biotech, Merck KGaA, Danaher, GE Healthcare, and Avantor.
The complete overview of the latest market research report on the global single-use bioprocessing market by Arizton is now available.
The report also offers a detailed study of major trends, drivers, challenges, and also provides the market size and forecast for major geographical regions and key countries.
Order a report: https://www.arizton.com/market-reports/single-use-bioprocessing-market
About Arizton Advisory & Intelligence
Arizton – Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize foolproof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including –Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Arizton Advisory & Intelligence
Chicago, Illinois, 60605
Mail: enquiry@arizton.com
Call: +1-312-465-7864
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Will Demand for Personalized Medicines Boost Sales in the Global Single-use Bioprocessing Market? | Arizton here
News-ID: 1389440 • Views: …
More Releases for R&D
Sales Acceleration Technology Market 2023: Sales and Industry Revenue Forecasts- …
The Sales Acceleration Technology market has witnessed growth from USD XX million to USD XX million from 2017 to 2023. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Sales Acceleration Technology market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological…
R&D Incentive Services Market is Booming Worldwide | KPMG, R&D Incentives, Deloi …
The latest report released on Global R&D Incentive Services Market analyses areas where there is still room for improvement. Irrespective of industry, organization size, or geographic location, the R&D Incentive Services Market study suggests that advanced technologies are playing a bigger role than ever before. The assessment provides trend, growth factors and estimates for Global R&D Incentive Services Market forecasted till 2028. Some of the key players profiled are KPMG…
Siveco doubles China R&D investment
On July 3, 2019, Siveco China held its half-year management meeting at the prestigious Hellas House in Shanghai, a nod to the company's continuing growth on the Belt & Road. With financial results above target, high customer satisfaction (as shown in the latest audited customer satisfaction survey) and a sales pipeline more promising than ever, the company's management board announced that shareholders have approved its request for additional investment in…
R&D Collaborative Projects by GD Rectifiers
GD Rectifiers have extensive experience in collaborative R&D projects and are proud to work with some of the UK’s pioneering power electronic companies to drive design and innovation forward.
This R&D service helps drive GD Rectifiers forward as a cutting edge manufacturer embracing fundamental technologies that support product development that contribute to next generation products throughout: renewable energy, embedded systems, smart metrering and the rail industry.
Power Assemblies, Controllers and…
Noliac is expanding the R&D team
Noliac is looking for two new colleagues for the R&D team in Prague, Czech Republic: A Precision/Fine Mechanics and an Electroengineer.
Precision/Fine Mechanics
For the R&D team in Prague, Czech Republic, Noliac is looking for a Precision/Fine mechanics to work on modifying existing products and work with developing new. Noliac requires a colleague who:
Is mechanically skilled with a focus on very small machinery.
Holds a technical high school degree or an apprenticeship…
Leiber GmbH further invests in R&D
Since February 2016, Leiber GmbH has been reinforced by Dr med vet Claudia Westfahl - a veterinarian specialized in animal nutrition - as part of the company's strategy to invest in new product developments. With the new position ‘Product Development Animal Nutrition’, Dr Westfahl is responsible for new product development in the field of functional feed ingredients for both pet as well as farm animals. After graduating at the University…